威尔药业
(603351)
| 流通市值：28.29亿 | | | 总市值：28.59亿 |
| 流通股本：1.34亿 | | | 总股本：1.35亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 173,254,720 | 117,441,106.1 | 128,322,164.94 | 99,827,619.02 |
| 应收票据及应收账款 | 177,766,307.75 | 164,894,933.77 | 152,574,670.5 | 151,137,005.14 |
| 应收账款 | 177,766,307.75 | 164,894,933.77 | 152,574,670.5 | 151,137,005.14 |
| 应收款项融资 | 64,630,225.18 | 33,208,769.31 | 21,233,144.56 | 17,656,994.84 |
| 预付款项 | 24,850,606.24 | 18,094,392.94 | 22,752,171.18 | 12,800,589.3 |
| 其他应收款合计 | 2,907,274.08 | 1,886,768.85 | 2,115,154.69 | 5,164,053.48 |
| 存货 | 157,933,130.68 | 179,168,891.18 | 185,884,308.49 | 165,129,389.22 |
| 其他流动资产 | 6,832,246.74 | 9,625,684.06 | 12,796,752.78 | 17,463,591.62 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 609,374,210.67 | 526,523,896.74 | 526,818,667.14 | 470,285,342.62 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 67,788,944.72 | 68,793,969.85 | 68,793,969.85 | 68,793,969.85 |
| 固定资产 | 626,751,539.81 | 596,953,994.47 | 612,283,294.56 | 622,896,920.39 |
| 在建工程 | 849,344,868.57 | 884,730,841.78 | 874,983,230.1 | 835,197,771 |
| 使用权资产 | 24,448,352.13 | 26,394,405.74 | 26,900,938.87 | 23,568,166.71 |
| 无形资产 | 92,197,073.88 | 93,049,039.35 | 92,883,937.66 | 93,528,689.71 |
| 开发支出 | 7,200,000 | 7,200,000 | - | - |
| 长期待摊费用 | 570,658.13 | 818,196.11 | 1,085,859.09 | 1,333,397.07 |
| 递延所得税资产 | 10,464,767.74 | 10,740,395.3 | 6,688,448.77 | 5,980,522.78 |
| 其他非流动资产 | 4,364,474.27 | 8,285,044.45 | 11,594,569 | 16,575,314.1 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,683,130,679.25 | 1,696,965,887.05 | 1,695,214,247.9 | 1,667,874,751.61 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,292,504,889.92 | 2,223,489,783.79 | 2,222,032,915.04 | 2,138,160,094.23 |
| 流动负债: | | | | |
| 短期借款 | 420,273,788.89 | 435,970,977.89 | 413,813,076.51 | 360,453,327.94 |
| 应付票据及应付账款 | 110,110,385.72 | 99,146,304.28 | 112,756,218.41 | 124,540,767.67 |
| 应付账款 | 110,110,385.72 | 99,146,304.28 | 112,756,218.41 | 124,540,767.67 |
| 合同负债 | 9,870,960.88 | 10,738,112.79 | 13,795,484.26 | 9,091,819.46 |
| 应付职工薪酬 | 18,121,344.5 | 13,614,746.45 | 9,234,723.12 | 19,875,203.52 |
| 应交税费 | 10,854,780.95 | 7,809,947.3 | 10,984,638.92 | 24,844,533.54 |
| 其他应付款合计 | 14,518,780.52 | 32,554,669.99 | 30,801,021.35 | 30,817,170.55 |
| 一年内到期的非流动负债 | 17,003,315.13 | 11,714,092.91 | 10,653,315.13 | 9,222,423.72 |
| 其他流动负债 | 1,283,224.91 | 1,363,124 | 1,782,766.38 | 1,175,778.06 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 602,036,581.5 | 612,911,975.61 | 603,821,244.08 | 580,021,024.46 |
| 非流动负债: | | | | |
| 长期借款 | 89,044,111.11 | 55,200,000 | 57,017,772.22 | 40,000,000 |
| 租赁负债 | 17,008,131.08 | 19,223,048.27 | 20,446,183.56 | 16,384,260.7 |
| 递延收益 | 12,780,800 | 7,340,800 | 7,170,800 | 6,500,000 |
| 递延所得税负债 | 11,873,954.51 | 12,255,158.23 | 13,389,128.36 | 12,850,860.71 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 130,706,996.7 | 94,019,006.5 | 98,023,884.14 | 75,735,121.41 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 732,743,578.2 | 706,930,982.11 | 701,845,128.22 | 655,756,145.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 135,439,132 | 135,478,432 | 135,478,432 | 135,478,432 |
| 资本公积 | 940,595,319.44 | 939,932,213.22 | 933,709,663.45 | 930,147,357.58 |
| 减:库存股 | 12,788,419.2 | 28,696,978.8 | 28,696,978.8 | 28,696,978.8 |
| 专项储备 | 3,763,704.33 | 2,553,293.49 | 985,791.75 | - |
| 盈余公积 | 60,928,214.35 | 60,928,214.35 | 60,849,415.33 | 60,849,415.33 |
| 未分配利润 | 422,772,282.56 | 397,887,174.67 | 408,824,314.34 | 382,513,582.15 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,550,710,233.48 | 1,508,082,348.93 | 1,511,150,638.07 | 1,480,291,808.26 |
| 少数股东权益 | 9,051,078.24 | 8,476,452.75 | 9,037,148.75 | 2,112,140.1 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,559,761,311.72 | 1,516,558,801.68 | 1,520,187,786.82 | 1,482,403,948.36 |
| 负债和股东权益合计 | 2,292,504,889.92 | 2,223,489,783.79 | 2,222,032,915.04 | 2,138,160,094.23 |
| 公告日期 | 2023-10-31 | 2023-08-29 | 2023-04-25 | 2023-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |